| __timestamp | Alnylam Pharmaceuticals, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 190249000 | 13673000 |
| Thursday, January 1, 2015 | 276495000 | 14358000 |
| Friday, January 1, 2016 | 382392000 | 12203000 |
| Sunday, January 1, 2017 | 390635000 | 18125000 |
| Monday, January 1, 2018 | 505420000 | 17071000 |
| Tuesday, January 1, 2019 | 655114000 | 20018000 |
| Wednesday, January 1, 2020 | 654819000 | 32788000 |
| Friday, January 1, 2021 | 792156000 | 44966000 |
| Saturday, January 1, 2022 | 883015000 | 311681000 |
| Sunday, January 1, 2023 | 1004415000 | 77707000 |
| Monday, January 1, 2024 | 1126232000 |
Unleashing the power of data
In the ever-evolving landscape of biopharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Alnylam Pharmaceuticals, Inc. and Lantheus Holdings, Inc. have demonstrated contrasting approaches to R&D investment. Alnylam's commitment to innovation is evident, with their R&D expenses growing by over 400% from 2014 to 2023. In 2023, their R&D spending reached a peak, accounting for nearly 90% of their total expenses. In contrast, Lantheus Holdings, Inc. has maintained a more conservative R&D budget, with a notable spike in 2022, where expenses surged by over 500% compared to the previous year. This divergence highlights the strategic choices companies make in the pursuit of groundbreaking therapies. As the industry continues to advance, these investments will play a pivotal role in shaping the future of healthcare.
Analyzing R&D Budgets: Merck & Co., Inc. vs Lantheus Holdings, Inc.
Comparing Innovation Spending: AstraZeneca PLC and Alnylam Pharmaceuticals, Inc.
R&D Spending Showdown: Alnylam Pharmaceuticals, Inc. vs BeiGene, Ltd.
Comparing Innovation Spending: Alnylam Pharmaceuticals, Inc. and Jazz Pharmaceuticals plc
Comparing Innovation Spending: Alnylam Pharmaceuticals, Inc. and Axsome Therapeutics, Inc.
Alnylam Pharmaceuticals, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Jazz Pharmaceuticals plc vs Lantheus Holdings, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and Verona Pharma plc
R&D Spending Showdown: Lantheus Holdings, Inc. vs Ultragenyx Pharmaceutical Inc.
R&D Insights: How Lantheus Holdings, Inc. and CRISPR Therapeutics AG Allocate Funds
R&D Insights: How Lantheus Holdings, Inc. and Xenon Pharmaceuticals Inc. Allocate Funds
Lantheus Holdings, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?